Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

China flag China · Delayed Price · Currency is CNY
73.72
-0.60 (-0.81%)
Nov 21, 2024, 11:29 AM CST
71.12%
Market Cap 30.23B
Revenue (ttm) 2.60B
Net Income (ttm) 740.69M
Shares Out 406.80M
EPS (ttm) 1.82
PE Ratio 40.84
Forward PE 29.83
Dividend 0.41 (0.54%)
Ex-Dividend Date n/a
Volume 1,109,194
Open 74.01
Previous Close 74.32
Day's Range 72.80 - 74.59
52-Week Range 42.06 - 86.11
Beta 0.45
Analysts n/a
Price Target n/a
Earnings Date Oct 24, 2024

About Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 1,960
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688278
Full Company Profile

Financial Performance

In 2023, Xiamen Amoytop Biotech's revenue was 2.10 billion, an increase of 37.55% compared to the previous year's 1.53 billion. Earnings were 555.45 million, an increase of 93.52%.

Financial Statements

News

There is no news available yet.